Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA · Nasdaq

Kailera Therapeutics, Inc. (KLRA) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Kailera Therapeutics, Inc. in 2026. The next earnings report is expected on September 2, 2026.

Scheduled earnings dates

02 Sep 2026 02 Dec 2026

Earnings calendar

Next earnings date

02 Sep 2026

In 14 days

EPS estimate

-0.80

Revenue estimate

0

Past earnings

12 Aug 2026
EPS actual
-1.09 (-21.6%)
estimate -0.90
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
26 May 2026
EPS actual
-3,650.00 (-470,867.7%)
estimate -0.78
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Kailera Therapeutics, Inc. missed consensus estimates in its latest earnings report, with EPS of -$1.09 versus an estimate of -$0.8967 and revenue of $0 that met estimates. In the prior report, EPS also missed expectations while revenue again met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Ronald C. Renaud Jr.
Employees
145
IPO date
17 Apr 2026
ISIN
US4829311020
Website
kailera.com

Frequently asked questions

When does Kailera Therapeutics, Inc. (KLRA) next report earnings?

Kailera Therapeutics, Inc. (KLRA) is scheduled to report earnings on September 2, 2026.

What was Kailera Therapeutics, Inc.'s most recent earnings date?

Kailera Therapeutics, Inc. (KLRA) last reported earnings on August 12, 2026.

Where is Kailera Therapeutics, Inc. stock listed?

Kailera Therapeutics, Inc. (KLRA) is listed on Nasdaq.